Insulin human (inhalation powder)

人胰岛素

Report date: 2024/12/18 14:11:53

Base Information

Drug NameInsulin human (inhalation powder)
Drug Alias NameInsulinum humanum (MannKind/Sanofi)人类胰岛素（MannKind/Sanofi）Insuline humaine (MannKind/Sanofi)Technosphere Insulin (MannKind/Sanofi)Pulmonary insulin (MannKind/Sanofi) +[10] 
ClassificationBiologics
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsHypoglycemiaGlucose IntoleranceHyperglycemia +[11] 
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/06/27
Country/TerritoryCzechiaBulgariaCanada +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMannKind Corp
China Registration ClassN/A

Develop Information

Active CompaniesMannKind CorpShanghai Jiao Tong University School of MedicineJaeb Center For Health Research Inc +[5] 
Inactive CompaniesYale UniversityModel Clinical Research Llc
Active IndicationsGlucose IntoleranceDiabetes Mellitus, Type 2Diabetes Mellitus +[6] 
Inactive IndicationsHypoglycemiaHyperglycemiaDiabetes Mellitus, Type 1 +[5] 

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksWikipediaDrugBankKEGG